SlideStrike transforms your pipeline data into presentations that regulators, investors, and physicians actually understand. Your clinical results deserve better than PowerPoint from scratch.
276 programs → 6 NDA submissions. Your investors need to see why.
Clinical data is complex. Your presentations don't have to be.
Auto-generate funnel charts, waterfall diagrams, and Gantt timelines from your pipeline data. Show investors exactly where value is created.
Kaplan-Meier curves, forest plots, safety summaries. Publication-quality charts in seconds, not hours with a biostatistician.
One dataset → investor pitch, FDA deck, physician detail aid, patient brochure. All consistent. All compliant.
MLR-friendly language. Fair balance reminders. Citation management. Built for FDA advisory committees and EMA submissions.
AI translates p-values and hazard ratios into narratives that non-scientists understand. Keep the rigor, lose the jargon.
AI validates numerical consistency across all slides. Never worry about a transcription error in front of the FDA again.
From discovery updates to FDA submissions.
Your Phase 3 data is groundbreaking. But the board doesn't speak p-values. Hours lost translating for non-scientists who control the budget.
One advisory committee meeting. 200 slides. A $2B drug approval on the line. No room for ambiguity, no tolerance for confusion.
Same data, five different audiences: physicians, payers, investors, regulators, patients. Five different decks. Five different deadlines.
Kaplan-Meier curves, forest plots, mechanism of action diagrams. Complex science that needs to be instantly understandable.
"We had 48 hours to prepare for an FDA advisory committee meeting. SlideStrike helped us generate 5 audience versions from the same clinical dataset. The committee chair said it was the clearest presentation they'd seen all year."
Communicate clinical data with the clarity and impact it deserves. From pipeline reviews to FDA submissions.